ANTI-EGFR OR ANTI-VEGF IN FIRST-LINE RAS WILD-TYPE METASTASTIC CRC PATIENTS: CAN WE DEFINE AN "OPTIM...
CALGB/SWOG 80405: Analysis of patients undergoing surgery as part of treatment strategy
A. Venook
CALGB/SWOG 80405: Analysis of patients undergoing surgery as part of treatment strategy
A. Venook